Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pillow

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioconjugate Chemistry|April 3, 2025
Mechanistic Characterization of the Potency of THIOMAB Antibody-Drug Conjugates Targeting <i>Staphylococcus aureus</i> and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug AccumulationHilda Hernandez-Barry, Josefa Dela Cruz-Chuh, Kimberly K Kajihara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 13, 2019
A Novel Depurination Methodology to Assess DNA Alkylation of Chloro-Bis-Seco-Cyclopropylbenzoindoles Allowed for Comparison of Minor-Groove ReactivityShuai Wang, Buyun Chen, Peter Dragovich, et al.
Molecular Cancer Therapeutics|December 4, 2020
An Anti-CD22-<i>seco</i>-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical ModelsShang-Fan Yu, Donna W Lee, Bing Zheng, et al.
Nature Communications|March 23, 2018
Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymesDavid S Hewings, Johanna Heideker, Taylur P Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid LeukemiaBing Zheng, Shang-Fan Yu, Geoffrey Del Rosario, et al.
Mbio|June 1, 2021
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic ConjugateKimberly K Kajihara, Homer Pantua, Hilda Hernandez-Barry, et al.
Nature Communications|January 11, 2024
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial resultsGail D Lewis, Guangmin Li, Jun Guo, et al.
Nature|November 5, 2015
Novel antibody-antibiotic conjugate eliminates intracellular S. aureusSophie M Lehar, Thomas Pillow, Min Xu, et al.
Chemical Science|April 13, 2022
A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptidesNeelie Zacharias, Vladimir N Podust, Kimberly K Kajihara, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioconjugate Chemistry|April 3, 2025
Mechanistic Characterization of the Potency of THIOMAB Antibody-Drug Conjugates Targeting <i>Staphylococcus aureus</i> and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug AccumulationHilda Hernandez-Barry, Josefa Dela Cruz-Chuh, Kimberly K Kajihara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 13, 2019
A Novel Depurination Methodology to Assess DNA Alkylation of Chloro-Bis-Seco-Cyclopropylbenzoindoles Allowed for Comparison of Minor-Groove ReactivityShuai Wang, Buyun Chen, Peter Dragovich, et al.
Molecular Cancer Therapeutics|December 4, 2020
An Anti-CD22-<i>seco</i>-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical ModelsShang-Fan Yu, Donna W Lee, Bing Zheng, et al.
Nature Communications|March 23, 2018
Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymesDavid S Hewings, Johanna Heideker, Taylur P Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid LeukemiaBing Zheng, Shang-Fan Yu, Geoffrey Del Rosario, et al.
Mbio|June 1, 2021
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic ConjugateKimberly K Kajihara, Homer Pantua, Hilda Hernandez-Barry, et al.
Nature Communications|January 11, 2024
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial resultsGail D Lewis, Guangmin Li, Jun Guo, et al.
Nature|November 5, 2015
Novel antibody-antibiotic conjugate eliminates intracellular S. aureusSophie M Lehar, Thomas Pillow, Min Xu, et al.
Chemical Science|April 13, 2022
A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptidesNeelie Zacharias, Vladimir N Podust, Kimberly K Kajihara, et al.
Pageof 1